Celebrex (celecoxib), the first COX-2 selective NSAID to hit the market

Patients are asking about Celebrex (celecoxib), the first COX-2 selective NSAID to hit the market.

Searle is launching it now in the U.S...soon in Canada.

Celebrex is approved for rheumatoid and osteoarthritis. It's as effective as other NSAIDs for joint pain and swelling.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote